We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 21-40 of 99 results
  1. Evaluating the use of novel atherogenicity indices and insulin resistance surrogate markers in predicting the risk of coronary artery disease: a case‒control investigation with comparison to traditional biomarkers

    Background

    Due to the contribution of coronary artery disease (CAD) to serious cardiovascular events, determining biomarkers that could robustly...

    Marjan Mahdavi-Roshan, Mohammad Mozafarihash**, ... Azita Hekmatdoost in Lipids in Health and Disease
    Article Open access 26 November 2022
  2. Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors

    Background and aims

    Non-high-density (HDL)-cholesterol, low-density lipoprotein (LDL)-particle number, apolipoprotein B, lipoprotein(a) (Lp(a)), and...

    Michael L. Dansinger, Paul T. Williams, ... Ernst J. Schaefer in Lipids in Health and Disease
    Article Open access 17 July 2019
  3. Sex difference in the relationship of the Atherogenic index of plasma with coronary artery lesions in diabetes: a cross-sectional study

    Background

    Coronary artery disease (CAD) tends to progress more rapidly in the type 2 diabetes mellitus (T2DM) population and may be associated with...

    Yi Hu, Xuan Wang, ... Gang Tian in Lipids in Health and Disease
    Article Open access 21 January 2023
  4. Atherogenic index of plasma is related to coronary atherosclerotic disease in elderly individuals: a cross-sectional study

    Background

    Dyslipidaemia plays an important role in coronary atherosclerotic disease (CAD). The relationship between the atherogenic index of plasma...

    Haomin Huang, **aolong Yu, ... Gaojun Cai in Lipids in Health and Disease
    Article Open access 11 July 2021
  5. Intermittent Fasting Regulates Metabolic Homeostasis and Improves Cardiovascular Health

    Obesity is a leading cause of morbidity and mortality globally. While the prevalence of obesity has been increasing, the incidence of its related...

    Rawan Diab, Lina Dimachkie, ... Ali H. Eid in Cell Biochemistry and Biophysics
    Article Open access 07 June 2024
  6. Decreased plasma lipid levels in a statin-free Danish primary health care cohort between 2001 and 2018

    Background

    Lipid levels in blood have decreased considerably during the past decades in the general population partly due to use of statins. This...

    Anna E. Engell, Henrik L. Jørgensen, ... Lise Bathum in Lipids in Health and Disease
    Article Open access 30 October 2021
  7. Oxidized Low-Density Lipoprotein: Preparation, Validation, and Use in Cell Models

    Lipoproteins in plasma are constituted by the least dense chylomicron, very-low-density lipoprotein (VLDL), low-density lipoprotein (LDL), and...
    Narayanasamy Angayarkanni, Kannadasan Anand Babu in Lipid Signalling
    Protocol 2024
  8. Non-fasting lipids detection and their significance in pregnant women

    Background

    The majority of pregnant women present an increase in lipids. To investigate the influence of the non-fasting state in the lipid and...

    Yulong Li, Jianxun He, ... Hui Yuan in Lipids in Health and Disease
    Article Open access 11 April 2019
  9. Common mechanisms underlying diabetic vascular complications: focus on the interaction of metabolic disorders, immuno-inflammation, and endothelial dysfunction

    Diabetic vascular complications (DVCs), including macro- and micro- angiopathy, account for a high percentage of mortality in patients with diabetes...

    Chongxiang Xue, Keyu Chen, ... **uyang Li in Cell Communication and Signaling
    Article Open access 30 October 2023
  10. Lipids and Cardiovascular Disease Risks with a Focus on Dairy Foods

    Cardiovascular diseases (CVD) remain a major cause of death and morbidity worldwide and dietary guidelines aim to restrict the intake of saturated...
    Chapter 2021
  11. Efficacy of a nutraceutical combination on lipid metabolism in patients with metabolic syndrome: a multicenter, double blind, randomized, placebo controlled trial

    Background

    Nutraceuticals represent a new therapeutic frontier in the treatment of metabolic syndrom (MetS) and related cardiovascular risk factors....

    Ferruccio Galletti, Valeria Fazio, ... Giampaolo Giacovelli in Lipids in Health and Disease
    Article Open access 18 March 2019
  12. Elevated postprandial triglyceride-rich lipoproteins in patients with diabetes and stable coronary artery disease correlated with early renal damage and systemic inflammation

    Background

    Dyslipidaemia is key in the development of coronary heart disease (CHD) in patients with diabetes mellitus (DM). Accumulated evidence...

    Xu Guo, Yujia Zhai, ... Daqing Zhang in Lipids in Health and Disease
    Article Open access 03 May 2023
  13. Systems Biology for Metabolic Disorder and Disease

    The simplistic approach frequently used in biological sciences is no longer sufficient if we want to research complicated multi-factorial illnesses...
    Chapter 2024
  14. Rho A/ROCK1 signaling-mediated metabolic reprogramming of valvular interstitial cells toward Warburg effect accelerates aortic valve calcification via AMPK/RUNX2 axis

    The aberrant differentiation of valvular interstitial cells (VICs) to osteogenic lineages promotes calcified aortic valves disease (CAVD), partly...

    Huiruo Liu, Hang Yin, ... Chuanbao Li in Cell Death & Disease
    Article Open access 11 February 2023
  15. Potential metabolic biomarkers of critical limb ischemia in people with type 2 diabetes mellitus

    Introduction

    Type 2 diabetes mellitus (T2DM) is a significant risk factor for the development of critical limb ischemia (CLI), the most advanced stage...

    Nahid Safari-Alighiarloo, Ahmad Mani-Varnosfaderani, ... Mohammad E. Khamseh in Metabolomics
    Article 14 July 2023
  16. Food and Plant Bioactives for Reducing Cardiovascular Disease Risk

    Cardiovascular diseases (CVDs) are the leading cause of mortality and disability worldwide, taking an estimated 17.9 million lives each year. The...
    Arrigo F. G. Cicero, Alessandro Colletti in Food Bioactives and Health
    Chapter 2021
  17. Non-HDL as a Valid Surrogate Marker of Small Dense LDL in a Young Indian Population

    Small dense (sd) LDL is a significant independent risk factor for premature coronary artery disease (CAD). Unfortunately, its estimation is not...

    Anjali Manocha, Seema Bhargava, ... Parul Chugh in Indian Journal of Clinical Biochemistry
    Article 08 May 2018
  18. The sensibility of the new blood lipid indicator——atherogenic index of plasma (AIP) in menopausal women with coronary artery disease

    Background

    Dyslipidemia is a key driver of coronary artery disease (CAD) development. This study aimed to determine whether the atherogenic index of...

    Qianyun Guo, Shu Zhou, ... Yujie Zhou in Lipids in Health and Disease
    Article Open access 24 February 2020
  19. Non-invasive skin cholesterol testing: a potential proxy for LDL-C and apoB serum measurements

    Background

    Lipid management is the first line of treatment for decreasing the incidence of cardiovascular events in patients with coronary heart...

    Jiacheng Lai, Yongsheng Han, ... Qingtong Wang in Lipids in Health and Disease
    Article Open access 17 October 2021
  20. Measured Versus Calculated Small Dense LDL-Cholesterol and Cardiometabolic Traits in a South African Population

    Small-dense low density lipoprotein (sdLDL) is increasingly viewed as a marker for evaluating atherogenic risk, however its clinical uptake is...

    M. Masoud, A. P. Kengne, ... T. E. Matsha in Indian Journal of Clinical Biochemistry
    Article 22 March 2018
Did you find what you were looking for? Share feedback.